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Natural producta b s t r a c t
Schistosomiasis is one of the most important parasitic infections in humans that occur in many tropical
and subtropical countries. Currently, the control of schistosomiasis rests with a single drug, praziquantel,
which is effective against adult worms but not the larval stages. Recent studies have shown that piplar-
tine, an amide isolated from plants of the genus Piper (Piperaceae), reveals interesting antischistosomal
properties against Schistosoma mansoni adult worms. Here, we report the in vitro antischistosomal activ-
ity of piplartine on S. mansoni schistosomula of different ages (3 h old and 1, 3, 5, and 7 days old), and
examine alterations on the tegumental surface of worms by means of confocal laser scanning microscopy.
Piplartine at a concentration of 7.5 lM caused the death of all schistosomula within 120 h. The lethal
effect occurred in a dose-dependent manner and was also dependent on the age of the parasite. Micros-
copy observation revealed extensive tegumental destruction, including blebbing, granularity, and a
shorter body length. This report provides the ﬁrst evidence that piplartine is able to kill schistosomula
of different ages and reinforce that piplartine is a promising compound that could be used for the devel-
opment of new schistosomicidal agent.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction to threaten millions of people, particularly in poor regions (King,Schistosomiasis or bilharziasis is a neglected tropical disease
caused by worms of the genus Schistosoma. The disease continuessevier OA license. 
em Saúde, SUVIS Casa Verde,
eida, 73, CEP 02517-150, São
usp.br (J. Moraes).2010). It has been estimated that there are more than 207 million
people infected worldwide, with 779 million people at risk of
infection (Steinmann et al., 2006). At least 280,000 people die each
year of schistosomiasis and the subtle morbidities associated with
chronic infection have a more serious impact than hitherto cred-
ited (van der Werf et al., 2003; King et al., 2005). The bloodﬂuke
Schistosoma mansoni is the major causative agent of human schis-
tosomiasis, affecting people in Africa, the Middle East, South
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contact with infested fresh water. Following the penetration of
the host skin, cercariae lose their tails and transform into schisto-
somula, which reside in the skin for up to 72 h before entering a
blood vessel. After a lung passage, the parasites move to the portal
venous system, where they mature into male and female worms
and mate, producing hundreds of eggs daily. Schistosomes can live
for years or even decades in human hosts and, hence, the disease
runs a chronic and debilitating course (Gryseels et al., 2006).
Despite the public health importance of schistosomiasis, the
treatment and control of this disease relies on a single drug, prazi-
quantel, an isoquinoline–parazine derivative. However, drug resis-
tance is an imminent threat, which underscores the need for
alternative therapies (Caffrey, 2007; Doenhoff et al., 2008). In addi-
tion, there is an important deﬁciency in the therapeutic proﬁle of
praziquantel, as it lacks activity against larval developing stages of
the parasite; hence, retreatment is necessary to kill those parasites
that have since matured (Utzinger et al., 2003). Accordingly, it is
imperative todevelopneweffectivedrugs for treatmentandpreven-
tion of the infection. Currently, there is also an urgent need to search
for drugs as prophylactic agents, being hence able to kill immature
forms. Ideally, a single drug should have broad effectiveness against
schistosomula and adult worms (Moraes, 2012; Veras et al., 2012).
Piplartine, 5,6-dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-
propenyl]-2(1H)-pyridinone, is an amide found in several plants of
the genus Piper (Piperaceae family). It is one of the major amide
isolated from Piper tuberculatum, whose plant has been largely
used in the folk medicine by several communities. As an advantage,
Piper species are widely distributed in tropical and subtropical
countries and piplartine is found in various parts of the plants,
especially in the root (Jaramillo and Manos, 2001; Navickiene
et al., 2003). Several biological activities of piplartine have been ex-
plored such as antitumor, antinociceptive, antidepressant and anx-
iolytic properties, as well as antiplatelet aggregation, insecticidal,
antifungal, and antiparasitic activities (Navickiene et al., 2000,
2003; Vasques da Silva et al., 2002; Tsai et al., 2005; Bezerra
et al., 2007; Bodiwala et al., 2007; Cícero Bezerra Felipe et al.,
2007; Cotinguiba et al., 2009; Rodrigues et al., 2009). Additionally,
recent study has shown that piplartine reveals interesting antis-
chistosomal properties (Moraes et al., 2011). This natural com-
pound is highly effective against S. mansoni adult male and
female worms, and it is able to reduce egg production when worms
are treated with sub-lethal concentration. In this study we present,
to our knowledge, the ﬁrst description of the effect of piplartine on
S. mansoni schistosomula. In addition, we showed that piplartine
caused alterations in the tegumental surface of schistosomula
using confocal laser scanning microscopy.2. Material and methods
2.1. Plant material
The plant material was collected in September of 2005 from a
specimen of P. tuberculatum growing under greenhouse conditions
at the Institute of Chemistry (Universidade de São Paulo, SP, Brazil),
and it was identiﬁed by Dr. Guillermo E. D. Paredes (Universidad
Pedro Ruiz Gallo, Lambayeque, Peru). The voucher specimen
(Kato-169) was deposited at the Herbarium of the Institute of
Biosciences (Universidade de São Paulo, SP, Brazil) as previously
described (Moraes et al., 2011).Fig. 1. Chemical structure of piplartine [5,6-dihydro-1-[1-oxo-3-(3,4,5-trimethoxy-
phenyl)-2-propenyl]-2(1H)-pyridinone].2.2. Extraction and isolation of piplartine
Piplartine was isolated from P. tuberculatum Jacq as previously
described (Navickiene et al., 2000). Brieﬂy, a dry powder ofinﬂorescences from P. tuberculatum (500 g) was extracted with
MeOH (2 x 2 l) at room temperature during 3 days. The solutions
were ﬁltered and concentrated under vacuum conditions, yielding
dark syrup (47 g). Part of this extract (2 g) was submitted to a silica
chromatography column using a gradient of hexane–EtOAc at
increasing polarities, which yielded 35 fractions. Fraction 20
(350 mg) was re-crystallized with hot MeOH; a white crystalline
compound was obtained (150 mg) and was identiﬁed as piplartine
(Fig. 1) by 1H NMR analysis.
2.3. Parasite
S. mansoni (BH strain Belo Horizonte, Brazil) worms have been
maintained in Biomphalaria glabrata snails as intermediate hosts
andMesocricetus auratus hamsters as deﬁnitive hosts at the Parasi-
tology Laboratory (Butantan Institute, São Paulo, Brazil).
2.4. Preparation of schistosomula and assessment of drug effect
Cercariae were shed from infected snails by exposure to light at
37 C for 2 h and subsequently converted to schistosomula by
mechanical transformation, using a Vortex mixer as described by
Ramalho-Pinto et al. (1974). Schistosomula were cultivated in
169medium containing antibiotics and supplemented with 10% fe-
tal bovine serum at 37 C in a 5% CO2 atmosphere (Basch, 1981).
The schistosomula were cultured until day 7, which corresponds
to the skin- and lung-stage worm (Moraes, 2012; Veras et al.,
2012).
For in vitro drug assays, schistosomula of different ages in vitro
(3 h old and 1, 3, 5, and 7 days old) were used. After the culturing
period for each age, these schistosomula were transferred to 96-
well culture microplates (approximately 150 parasites per well)
and cultured as already described (37 C, 5% CO2) in 169 medium
in the presence of piplartine at various concentrations. The ﬁnal
volume in each well was 200 ll. Schistosomula incubated in med-
ium containing 0.5% DMSO, the highest concentration of drug sol-
vent used, served as a negative control group. In some
experiments, praziquantel at 20 lM (Merck, Rio de Janeiro, RJ, Bra-
zil) was used as positive control group. All the experiments were
performed in triplicate. The culture plates were monitored on a
daily basis for 5 days using an inverted microscope. Parasite death
was deﬁned as no movement for at least 1 min of examination
(Moraes, 2012). Schistosomula death was also conﬁrmed by a try-
pan blue dye exclusion test (Harrop andWilson, 1993). The activity
was measured by calculating the percentage of the number of dead
worms compared to the total number of worms.
2.5. Confocal laser scanning microscopy with schistosomula
In order to observe morphological changes on tegument, schis-
tosomula were monitored using a confocal laser scanning micro-
scope as previously described (de Moraes et al., 2011; Moraes
et al., 2011). Brieﬂy, after established times or in the occurrence
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alcohol solution (FAA) and analyzed under a confocal microscope
(Confocal Laser Scanning Microscopy, LSM 510 META, Zeiss) at
488 nm excitation and 505 nm emission (Moraes et al., 2009).
2.6. Ethics statement
This study was approved by the Institutional Review Board of
the Instituto Butantan (approval number: 814/11). All the animals
were handled in strict accordance with good animal practice as
deﬁned by the Animals Use Ethics Committee of the Instituto
Butantan (São Paulo, Brazil). The study was conducted in adher-
ence to the institution’s guidelines for animal husbandry.
2.7. Statistical analysis
Statistical tests were performed with GRAPHPAD PRISM (ver-
sion 5.0) software. Signiﬁcant differences were determined by a
one-way analysis of variance (ANOVA) and by applying Tukey’s
test for multiple comparisons with the level of signiﬁcance set at
P < 0.05.Fig. 2. In vitro effect of piplartine on the survival of 3 h old and 1, 3, 5, and 7 days
old S. mansoni schistosomula. Parasites of different ages were incubated in 24-well
culture plates containing 169 medium and treated with piplartine at different
concentrations for the time periods indicated. Mortality data are the average of
three separate experiments.3. Results and Discussion
The control of schistosomiasis relies on a single drug, prazi-
quantel, which is effective against adult worms but not the larval
stages. Recently, many scientiﬁc research centers around the world
are screening substances originating from plants for schistosomi-
cidal activity (Magalhães et al., 2009, 2010; Caixeta et al., 2011;
Pereira et al., 2011; Moraes, 2012). In this sense, in vitro promising
antischistosomal properties of piplartine, an amide found in Piper
species, against adult schistosomes has been reported (Moraes
et al., 2011). However, no study with piplartine against schisto-
somula has been performed. To further deepen our understanding
of the activity of this natural compound against schistosomes, we
investigated the in vitro effect of piplartine on S. mansoni of differ-
ent ages (3 h old and 1, 3, 5, and 7 days old schistosomula) as well
as tegumental alterations of piplartine on parasites.
3.1. Antischistosomal activity of piplartine on S. mansoni
schistosomula of different ages
S. mansoni schistosomula of different ages (3 h old and 1, 3, 5,
and 7 days old) were cultured in vitro in the presence of different
concentrations of amide piplartine and mobility and death were
monitored. In the presence of piplartine, all schistosomula died
at concentrations of 7.5 lM after 120 h. In contrast, the worms in
the control group remained viable until the end of the incubation
period (Fig. 2 and data not shown). Interestingly, the lethal effect
occurred in a dose-dependent manner and was also dependent
on the age of the parasite. As shown in Fig. 2, piplartine at a con-
centration of 15 lM caused the death of 100% of 5 and 7 day old
schistosomula, after 72 and 48 h, respectively. Furthermore, at this
same concentration (15 lM), the compound was able to kill all 3 h
old and 1 and 3 day old schistosomula only after 96 h. Therefore,
older (lung-stage) schistosomula appeared highly more sensitive
to piplartine schistosomicidal activity than younger schistosomula
(newly transformed- and skin-stage).
As previously mentioned, schistosomula are not susceptible to
praziquantel (Utzinger et al., 2003). In this study, we also evaluated
the effect of praziquantel on schistosomula of different in vitro age,
but no death was detected after treatment at concentration as high
as 20 lM (results not shown). In contrast, our in vitro data demon-
strated that piplartine exhibits a strong schistosomicidal action
against schistosomula at concentrations as low as 7.5 lM. Addi-tionally, piplartine has been as effective as praziquantel to kill
adult stage of S. mansoni and their schistosomicidal activity was
demonstrated at a concentration of 9.5 lM (Moraes et al., 2011).
Thus, piplartine is a promising compound that could be used for
the development of new schistosomicidal agent.
3.2. Confocal laser scanning microscopy investigations
In addition to mortality rate, morphological changes on tegu-
ment were monitored microscopically. In the absence of the drug,
all schistosomula, regardless of age, showed normal viability with-
out any morphological changes for up to 120 h. In contrast, tegu-
mental changes were observed when schistosomes have been
exposed to the piplartine at lethal concentrations above 7.5 lM.
Fig. 3. Effect of piplartine on the tegument of 3 h old and 1, 3, 5, and 7 days old S.
mansoni schistosomula. Parasites of different ages were incubated in 24-well
culture plates containing 169 medium and treated with piplartine. After occurrence
of death, schistosomula were ﬁxed in FAA solution and ﬂuorescent images were
obtained using confocal laser scanning microscopy (Carl Zeiss LSM 510 META). The
images were analyzed with the Zeiss LSM Image Browser software; (A) 3 h old
schistosomula; negative control, (B) 3 h old schistosomula; piplartine 7.5 lM, (C)
1 day old schistosomula; negative control, (D) 1 day old schistosomula; piplartine
7.5 lM, (E) 3 day old schistosomula; negative control, (F) 3 day old schistosomula;
piplartine 7.5 lM, (G) 5 day old schistosomula; negative control, (H) 5 day old
schistosomula; piplartine 7.5 lM, (I) 7 day old schistosomula; negative control, and
(J) 7 day old schistosomula; piplartine 7.5 lM. Bars = 25 lm.
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old schistosomula, all parasites showed minimal activity, including
convulsions and contractions. However, after occurrence of death,
several morphological changes on the body region such as several
scattered blebs, granularity, and a shorter body length were ob-
served due to exposure to piplartine at lethal concentrations
(Fig. 3 and data not shown).
The major interface between the schistosome and its external
environment is through the tegument (Skelly and Alan Wilson,
2006). Thus, the tegument has been identiﬁed as a key target of
some schistosomicidal compounds. The surface topography of S.
mansoni schistosomula as studied by microscopy has been re-
ported in great details in previous study (Crabtree and Wilson,
1980; Basch and Basch, 1982). The structure and appearance of S.
mansoni schistosomula incubated in absence of piplartine were
similar to those described in the literature (Manneck et al., 2010;
Veras et al., 2012). Likewise, morphological effects and tegumental
alterations induced by piplartine on schistosomula were similar to
those observed for parasites incubated with other antischistosomal
compound such as meﬂoquine (Manneck et al., 2010).
Previous studies have shown that piplartine exhibits broad
range of biological activities in vitro and in vivo (Bezerra et al.,
2005, 2006, 2008a, 2009). For example, Tsai et al. (2005) showed
that piplartine has potent anti-platelet aggregation activity induced
by collagen in vitro (Tsai et al., 2005). More recently, Fontenele
et al. (2009) demonstrated that antiplatelet effects of piplartine
are due to the possible involvement of cyclooxygenase blockade
and antioxidant activity; moreover, the authors also reported that
piplartine shows anti-inﬂammatory effects similar to that occur-
ring with aspirin, a well-known inhibitor of cyclooxygenase.
Furthermore, piplartine isolated from different Piper species
possesses antitumor activity both in vitro and in vivo, which is
due to induced toxicity, and this amide may be a promising candi-
date to combat cancer (Bezerra et al., 2005, 2006, 2008a). In this
context, toxicological aspects of the treatment with piplartine have
been studied. For example, piplartine had no effect on the spleen of
treated animals, and apparently has the kidney as the main toxico-
logical target; however, the kidney damage observed in piplartine-
treated animals could also be considered reversible (Bezerra et al.,
2006, 2008a). Hematological analysis showed that piplartine also
normalize the leukocytes proportions and this amide did not in-
duced hemolysis of mouse erythrocytes (Bezerra et al., 2005,
2008a). Conversely, piplartine possesses DNA damaging potential
in mammalian cells as well as mutagenic and recombinogenic ef-
fects on yeast (Bezerra et al., 2008b, 2009). Regarding the antis-
chistosomal properties, it was previously shown that piplartine
has selective antiparasitic activity and exhibited no cytotoxicity
when incubated monkey kidney ﬁbroblasts (Moraes et al., 2011).
In vitro sensitivity testing has been important in the screening
of new anthelmintic agents, but the assessment of therapeutic
activity using in vivo models should be performed (Moraes,
2012). Importantly, in vivo studies with piplartine have been previ-
ously demonstrated in animal models. For example, Bodiwala et al.
(2007) showed signiﬁcant antileishmanial activity of piplartine at
30 mg/kg, administered intraperitoneally, in Leishmania donovani-
infected hamsters. Additionally, it has been demonstrated that
piplartine (0.0001–30 mg/kg, administered intraperitoneally)
exhibited signiﬁcant and dose-related antinociceptive effects
against acetic acid-induced visceral pain in mice, supporting
the ethnomedical use of Piper species as analgesic and sedative
(Rodrigues et al., 2009).
The mechanism by which piplartine exert their in vitro schistos-
omicidal effects is not clear. However, it has been reported that the
in vitro effects of piplartine on S. mansoni adults better correlate
with the muscular function (motor activity) than with the tegu-
mental destruction (Moraes et al., 2011). Recently, Cícero Bezerra
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antidepressant effects in mice; the authors suggest that this amide
interacts with the neurotransmission system, which make this
drug potentially useful in anxiety and depression. Therefore, the
in vitro antischistosomal effects of piplartine may be related to
the inhibition of neurotransmission system pathway in S. mansoni.
Importantly, the nervous systems of schistosomes and other hel-
minths have been considered as important targets for drugs (Geary
et al., 1992; Cioli et al., 1995; Thompson et al., 1996; Sangster et al.,
2005). However, further studies are required to correlate these
neural effects with the schistosomicidal action of piplartine.
Taken together, those previous ﬁndings mentioned and the re-
sults presented here indicate the potential of piplartine towards
schistosomiasis treatment. Nevertheless, considering that piplar-
tine induces in vivo and in vitro mutagenicity in eukaryotic models
(Bezerra et al., 2008b, 2009) further studies are needed to identify
the mechanisms involved in the biological activity of this com-
pound. Since piplartine showed selective antischistosomal activity
and exhibited no cytotoxicity to mammalian cells (Moraes et al.,
2011), experiments to evaluate this amide in vivo in mice infected
with S. mansoni and in vitro assays with structural analogs are also
important to characterize the antischistosomal effect in greater
detail.
3.3. Conclusions
The results of this study indicated that piplartine is an efﬁcient
compound against S. mansoni schistosomula in vitro. In addition,
results obtained from direct observation of the schistosomula via-
bility and confocal microscopy strongly suggest that piplartine is
more effective than praziquantel. Therefore, considering the schist-
osomicidal effects against larval- and adult-stage of S. mansoni,
piplartine may represent a step forward in the search for novel
antischistosomal agents, at a time when there is an urgent need
for novel drugs. Experiments to evaluate this natural amide
in vivo onto mice infected by S. mansoni are under progress, besides
biological studies to elucidate their mechanism(s) of schistosomi-
cidal action.
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